Viome ratings $86.5M and launches intestine take a look at into CVS


Viome Lifestyles Sciences introduced it closed a $86.5 million oversubscribed Collection C investment spherical, bringing its general lift to $175 million. 

Daring Capital and Khosla Ventures participated within the spherical along present and new buyers. 

The corporate additionally introduced the release of its Intestine Intelligence Take a look at in 200 CVS places. 


The corporate gives a complete frame intelligence take a look at for customers to procure meals suggestions and create custom-formulated dietary supplements and probiotics, which the corporate additionally develops and distributes. 

Viome additionally gives an oral well being intelligence take a look at with its VRx My·Biotics Oral Lozenges focused at comparing and making improvements to one’s oral micro organism. 

The Washington-based corporate’s Intestine Intelligence Take a look at, to be had thru CVS on-line and in-store, evaluates one’s digestive potency, intestine lining well being, gasoline manufacturing, protein fermentation, inflammatory process, metabolic health, intestine energetic microbial variety, and microbiome-induced tension. The purpose is to lend a hand one perceive their intestine well being and procure suggestions for probiotic traces and prebiotic fibers.

The corporate will use the budget from the Collection C spherical to additional analysis and broaden its suite of well being assessments and proceed its enlargement into shops. 

“Amidst the surge in power stipulations and the inflow of conflicting nutritional recommendation flooding social media, it turned into glaring {that a} seismic shift was once essential. At Viome, we are not simply speaking about wellness; we’re growing an entire new figuring out of what it approach to be wholesome by means of addressing the basis reason for problems and now not simply the indicators. By means of combining our deep figuring out of particular person forte and the microbiome with state of the art RNA sequencing and AI era, we are in a position to translate knowledge into actionable insights that may profoundly have an effect on our healthspan and lifespan. I believe thankful to have the make stronger of buyers and companions who in point of fact perceive and admire our groundbreaking paintings. The most recent investment and our enlargement into CVS constitute extra than simply industry milestones; they are a testomony to our dedication and a possibility for us to boost up our studying as we get nearer to reaching our venture of serving to billions of folks are living higher lives,” Naveen Jain, founder and CEO of Viome, advised MobiHealthNews in an e mail.  


In 2021, Viome introduced it raised $54 million in a pre-Collection C convertible investment spherical. The corporate scored $56 million in Collection B investment in 2019 and $15 million in August 2017.  

Viome gained FDA leap forward tool designation for its mRNA research era and AI platform in 2021 that detects early indicators of oral and throat most cancers thru consumer saliva samples. 

Different corporations providing domestic trying out kits come with Reperio Well being, the maker of an app-connected domestic wellness evaluation equipment advertised to employers; domestic diagnostics corporate Cue Well being; and Everly Well being, the dad or mum corporate of at-home diagnostics startup EverlyWell and being pregnant and fertility-focused Natalist.



Please enter your comment!
Please enter your name here

Share post:


More like this